Combination cancer immunotherapies tailored to the tumour microenvironment DOI
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas

et al.

Nature Reviews Clinical Oncology, Journal Year: 2015, Volume and Issue: 13(3), P. 143 - 158

Published: Nov. 24, 2015

Language: Английский

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 DOI Creative Commons
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson

et al.

Cell Death and Differentiation, Journal Year: 2018, Volume and Issue: 25(3), P. 486 - 541

Published: Jan. 23, 2018

Over the past decade, Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for definition and interpretation of cell death from morphological, biochemical, functional perspectives. Since field continues to expand novel mechanisms that orchestrate multiple pathways are unveiled, we propose an updated classification subroutines focusing mechanistic essential (as opposed correlative dispensable) aspects process. As provide molecularly oriented definitions terms including intrinsic apoptosis, extrinsic mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic death, NETotic lysosome-dependent autophagy-dependent immunogenic cellular senescence, mitotic catastrophe, discuss utility neologisms refer highly specialized instances these processes. The mission NCCD is a widely accepted nomenclature in support continued development field.

Language: Английский

Citations

5351

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies DOI
Jérôme Galon, Daniela Bruni

Nature Reviews Drug Discovery, Journal Year: 2019, Volume and Issue: 18(3), P. 197 - 218

Published: Jan. 4, 2019

Language: Английский

Citations

2622

Immunogenic cell death in cancer and infectious disease DOI
Lorenzo Galluzzi,

Aitziber Buqué,

Oliver Kepp

et al.

Nature reviews. Immunology, Journal Year: 2016, Volume and Issue: 17(2), P. 97 - 111

Published: Oct. 17, 2016

Language: Английский

Citations

2435

Dendritic cells in cancer immunology and immunotherapy DOI
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal

et al.

Nature reviews. Immunology, Journal Year: 2019, Volume and Issue: 20(1), P. 7 - 24

Published: Aug. 29, 2019

Language: Английский

Citations

1984

Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing DOI
Qi Chen, Lijun Sun, Zhijian J. Chen

et al.

Nature Immunology, Journal Year: 2016, Volume and Issue: 17(10), P. 1142 - 1149

Published: Sept. 20, 2016

Language: Английский

Citations

1750

Inflammation and tumor progression: signaling pathways and targeted intervention DOI Creative Commons

Huakan Zhao,

Lei Wu,

Guifang Yan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: July 12, 2021

Abstract Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses tumor progression, potentially displaying opposing effects on therapeutic outcomes. Chronic inflammation facilitates progression treatment resistance, whereas induction of acute inflammatory reactions often stimulates the maturation dendritic cells (DCs) antigen presentation, leading anti-tumor immune responses. In addition, multiple signaling pathways, such as nuclear factor kappa B (NF-kB), Janus kinase/signal transducers activators transcription (JAK-STAT), toll-like receptor (TLR) cGAS/STING, mitogen-activated protein kinase (MAPK); factors, including cytokines (e.g., interleukin (IL), interferon (IFN), necrosis (TNF)-α), chemokines C-C motif chemokine ligands (CCLs) C-X-C (CXCLs)), growth factors vascular endothelial (VEGF), transforming (TGF)-β), inflammasome; well metabolites prostaglandins, leukotrienes, thromboxane, specialized proresolving mediators (SPM), have been identified pivotal regulators initiation resolution inflammation. Nowadays, local irradiation, recombinant cytokines, neutralizing antibodies, small-molecule inhibitors, DC vaccines, oncolytic viruses, TLR agonists, SPM developed specifically modulate in cancer therapy, with some these already undergoing clinical trials. Herein, we discuss crosstalk between processes. We also highlight potential targets for harnessing cancer.

Language: Английский

Citations

1636

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity DOI Creative Commons
Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil

et al.

Nature Communications, Journal Year: 2017, Volume and Issue: 8(1)

Published: June 9, 2017

Abstract Radiotherapy is under investigation for its ability to enhance responses immunotherapy. However, the mechanisms by which radiation induces anti-tumour T cells remain unclear. We show that DNA exonuclease Trex1 induced doses above 12–18 Gy in different cancer cells, and attenuates their immunogenicity degrading accumulates cytosol upon radiation. Cytosolic stimulates secretion of interferon-β following activation sensor cGAS downstream effector STING. Repeated irradiation at do not induce amplifies production, resulting recruitment Batf3-dependent dendritic cells. This effect essential priming CD8 + mediate systemic tumour rejection (abscopal effect) context immune checkpoint blockade. Thus, an upstream regulator radiation-driven immunity. induction may guide selection dose fractionation patients treated with

Language: Английский

Citations

1448

The cGAS–STING pathway as a therapeutic target in inflammatory diseases DOI Open Access
Alexiane Decout, Jason D. Katz,

Shankar Venkatraman

et al.

Nature reviews. Immunology, Journal Year: 2021, Volume and Issue: 21(9), P. 548 - 569

Published: April 8, 2021

Language: Английский

Citations

1369

Molecular mechanisms and cellular functions of cGAS–STING signalling DOI
Karl‐Peter Hopfner, Veit Hornung

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 21(9), P. 501 - 521

Published: May 18, 2020

Language: Английский

Citations

1323

CD4+ T cell help in cancer immunology and immunotherapy DOI
Jannie Borst, Tomasz Ahrends,

Nikolina Bąbała

et al.

Nature reviews. Immunology, Journal Year: 2018, Volume and Issue: 18(10), P. 635 - 647

Published: July 29, 2018

Language: Английский

Citations

1287